Vallon Pharmaceuticals, Inc. (VLON) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 11 transactions totaling $105.0K, demonstrating a bullish sentiment with $105.0K in net insider flow. The most recent transaction on Dec 13, 2022 involved a transaction of 28,517 shares valued at $0.
No significant insider buying has been recorded for VLON in the recent period.
No significant insider selling has been recorded for VLON in the recent period.
Based on recent SEC filings, insider sentiment for VLON is bullish with an Insider Alignment Score of 100/100 and a net flow of $105.0K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Vallon Pharmaceuticals, Inc. (VLON) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading VLON stock, having executed 11 transactions in the past 90 days. The most active insider is Pharma Gmbh Salmon (Executive), who has made 1 transactions totaling $301.2K.
Get notified when executives and directors at VLON file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 13, 2022 | Thorell Marella | Executive | Other | 28,517 | $N/A | $0 | |
| Jul 1, 2022 | Thorell Marella | Executive | Award | 38,023 | $N/A | $0 | |
| Jun 4, 2021 | M. Kelly Leanne | Executive | Purchase | 1,508 | $4.08 | $6.2K | |
| Jun 3, 2021 | M. Kelly Leanne | Executive | Purchase | 1,085 | $4.05 | $4.4K | |
| Jun 2, 2021 | M. Kelly Leanne | Executive | Purchase | 3,657 | $4.00 | $14.6K | |
| May 26, 2021 | E. Payne Joseph | Executive | Purchase | 6,800 | $4.50 | $30.6K | |
| May 25, 2021 | E. Payne Joseph | Executive | Purchase | 10,700 | $3.85 | $41.2K | |
| Feb 12, 2021 | Charles Baker David | Executive | Other | 7,843 | $6.40 | $50.2K | |
| Feb 12, 2021 | Charles Baker David | Executive | Purchase | 1,000 | $8.00 | $8.0K | |
| Feb 12, 2021 | Gmbh Salmon Pharma | Executive | Other | 47,063 | $6.40 | $301.2K | |
| Feb 12, 2021 | Ammer Richard | Executive | Other | 47,063 | $6.40 | $301.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 4 | $652.6K | 86.1% |
Purchase(P) | 6 | $105.0K | 13.9% |
Award(A) | 1 | $0 | 0.0% |
Insiders at Vallon Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 6 insiders making 11 transactions totaling $105.0K in purchases versus $0 in sales, the net buying activity of $105.0K signals strong executive confidence. Pharma Gmbh Salmon (Executive) leads the buying activity with $301.2K in transactions across all time.